The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia

Barbara Depczynski, Vincent W Wong, Hamish D Russell and Nicole Opie
Med J Aust 2011; 195 (5): . || doi: 10.5694/mja11.10462
Published online: 5 September 2011

To the Editor: The Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study, a large, blinded, multinational study, showed an increased risk of adverse maternal and neonatal outcomes in relation to maternal glycaemia, at glucose levels below the current Australian criteria for diagnosing gestational diabetes mellitus (GDM).1 The International Association of Diabetes and Pregnancy Study Groups (IADPSG), an international consensus group, has proposed new criteria for the diagnosis of GDM.2 As a result, these new criteria have been adopted by the American Diabetes Association, which predicts a significant increase in the prevalence of GDM.3

  • Barbara Depczynski
  • Vincent W Wong
  • Hamish D Russell
  • Nicole Opie

  • Diabetes and Endocrinology, Liverpool Hospital, Sydney, NSW.

Competing interests:

Barbara Depczynski and Hamish Russell have received payments for lectures to their institutions from Lilly and Novo Nordisk (BD) and Novo Nordisk and Sanofi Aventis (HR).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.